Vulvovaginal candidiasis

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
3 Unique IMPs
2 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Azole antifungal 3 substances
Phase II: 1 Phase I (First in Human): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Palau Pharma S.L. Commercial
    ALBACONAZOLE; FLUCONAZOLE; ITRACONAZOLE
    2023-504727-32-00 2 countries 2023 n=702
    Ended

Phase I (First in Human)

1 trial
  • LimmaTech Biologics AG Commercial
    IMP not specified
    2023-507527-28-00 2 countries 2024 n=251
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Palau Pharma S.L. Commercial 1 Phase II 0
LimmaTech Biologics AG Commercial 1 Phase I (First in Human) 0
New trials by year
2023
1
2024
1
← All indication landscapes